Literature DB >> 34346733

Conceptualizing the COVID-19, Opioid Use, and Racism Syndemic and Its Associations With Traumatic Stress.

Denise Nguyen Hien1, Alexandria G Bauer1, Liza Franklin1, Tanya Lalwani1, Kierra Pean1.   

Abstract

Individually, the COVID-19 pandemic and opioid epidemic have each been responsible for hundreds of thousands of deaths. Systemic racism, including public perceptions about people who use opioids, inadequate substance abuse prevention and treatment efforts, heightened risks for COVID-19 exposure, and inadequate access to testing and health care, has contributed to the ongoing disparities underlying these health crises. Thus, the authors propose an integrative framework for conceptualizing the COVID-19, opioid use, and racism (COR) syndemic, with traumatic stress as a critical underpinning of this model. Action is needed to address trauma and the COR syndemic. Implications for research, practice, and policy are discussed.

Entities:  

Keywords:  COVID-19; Coronavirus; Drug abuse; Racial-ethnic disparities; Racism

Mesh:

Substances:

Year:  2021        PMID: 34346733     DOI: 10.1176/appi.ps.202100070

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  2 in total

1.  The Stress and Resilience Town Hall: A systems response to support the health workforce during COVID-19 and beyond.

Authors:  Jacob K Tebes; Michael N Awad; Elizabeth H Connors; Sarah K Fineberg; Derrick M Gordon; Ayana Jordan; Richard Kravitz; Luming Li; Allison N Ponce; Maya Prabhu; Susan Rubman; Michelle A Silva; Matthew Steinfeld; David C Tate; Ke Xu; John H Krystal
Journal:  Gen Hosp Psychiatry       Date:  2022-04-22       Impact factor: 7.587

Review 2.  Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.

Authors:  Anh Truc Vo; Thomas Patton; Amy Peacock; Sarah Larney; Annick Borquez
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.